Home › Funds › Two Sigma Investments › IRD
Two Sigma Investments position in IRD
OPUS GENETICS INC · Health Care
Latest position (Q2 2026)253.96K sh
Reported value held$1.04M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 36.88K | $190.00K | New |
| Q4 2021 | 119.90K | $447.00K | Add |
| Q1 2022 | 51.70K | $168.00K | Reduce |
| Q2 2023 | 19.09K | $82.83K | New |
| Q2 2025 | 40.19K | $37.86K | New |
| Q3 2025 | 108.34K | $178.76K | Add |
| Q4 2025 | 151.31K | $304.14K | Add |
| Q1 2026 | 108.64K | $494.32K | Reduce |
| Q2 2026 | 253.96K | $1.04M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IRD
- BlackRock Inc 3.12M sh · $12.81M · Q2 2026
- Balyasny Asset Management 3.09M sh · $12.69M · Q2 2026
- Millennium Management 2.30M sh · $9.46M · Q2 2026
- Marshall Wace 1.95M sh · $8.00M · Q2 2026
- Goldman Sachs Group 1.53M sh · $6.28M · Q2 2026
- Geode Capital Management 1.37M sh · $5.62M · Q2 2026
- Vanguard Group 2.32M sh · $4.67M · Q4 2025
- UBS Group AG 683.89K sh · $2.81M · Q2 2026
- Citadel Advisors 665.66K sh · $2.74M · Q2 2026
- Morgan Stanley 464.90K sh · $1.91M · Q2 2026
- Northern Trust Corp 442.15K sh · $1.82M · Q2 2026